亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Vaccine and Treatments for Recurrent Airway Obstruction (Rao) in Horses

詳細技術說明
Recurrent AirwayObstruction (RAO) is a serious respiratory disease similar to human asthmaaffecting as much as 15% of horse population around the world, persistingthroughout a horse’s life. This vaccine is the first-ever for the elimination of the diseaserather than symptom relief.
*Abstract

Most evidence suggests that RAO is the result of pulmonaryhypersensitivity to inhaled antigens located in hay dust, pollens and moldspores. Current methods of treatment include environmental and dietarymanagement as a means to reduce exposure to organic dusts and molds. Medicinaltreatments are directed towards symptomatic relief, and include the use ofbronchodilators and steroids—none of which completely eliminate or provide apermanent solution.

This technology is the first-ever vaccine for the eliminationof the disease rather than symptom relief. It consists of a unique peptidesequence derived from the Clara Cell 10kDa protein (CC10). CC10 is one memberof a family of anti-inflammatory defense proteins produced predominantly in theairway epithelium and some of the members of this family have been directlylinked to protection from asthma, allergy and related inflammatory responses.

*IP Issue Date
Jun 8, 2012
*IP Type
Utility
國家
United States
申請號碼
14/124,297
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備